regulatory approval

American Fusion Inc. completes 5MW Texatron structural frame in Texas and launches $5 million fundraise to support testing and system integration milestones.

Genius Sports positioned as data provider beneficiary of prediction markets boom. Stock trading at discount to 2026 revenue projections of $1.1B.

EyePoint reports 97% revenue decline to $0.7M in Q1 2026 amid $84.8M net loss, but maintains $223M cash runway through Q4 2027 as DURAVYU Phase 3 trials advance.

Global stem cell therapy market projected to grow from $21.9B in 2025 to $58.5B by 2034 at 11% CAGR, driven by technological advances and favorable regulations.

Oklo, NuScale, and GE Vernova vie for leadership in next-generation reactor markets amid surging energy demand and supportive policy.

WTW completes Cushon acquisition, becoming UK's fourth-largest master trust provider managing £30 billion for 1.2 million members.

Bullish acquires Equiniti for $4.2B in stock-and-debt deal, combining blockchain infrastructure with global transfer agent operations to capture tokenized securities market.

EU regulators probe Tesla's Full Self-Driving safety concerns over icy roads and speeding, threatening Elon Musk's $1 trillion compensation package tied to FSD and robotaxi milestones.

Hyperliquid's 70% market share in perpetual futures faces competitive threats from Coinbase, Kalshi, and Polymarket seeking regulatory approval under a pro-crypto administration.

Oklo, valued at $13B with zero revenue and $100M annual cash burn, represents extreme risk-reward. Meta backing and 14 GW backlog offer upside, but regulatory approval and commercialization remain unproven.

Telix Pharmaceuticals' glioma imaging candidate TLX101-Px gains European regulatory validation, entering 210-day review phase with potential market approval expected.

Northwest Biotherapeutics appoints experienced biopharma executive Dr. Annalisa Jenkins as Strategic Adviser to advance its DCVax dendritic cell cancer vaccine platform.

California Water Service reports Q1 2026 earnings down 70% YoY to $4.0M while awaiting rate case approval and planning $218M acquisition.

Hawthorn Bancshares to acquire FSC Bancshares for $28.3M cash-and-stock deal, creating $2.2B asset bank expected to boost earnings 20%.

Strategic Value Bank Partners acquires $11.6M stake in OceanFirst Financial ahead of Flushing Financial merger, projecting 16% EPS accretion by 2027.

Genius Sports ($GENI) stock down 60% but poised for upside as prediction markets expand and regulators mandate official sports data usage.

OceanFirst and Flushing Financial secure all regulatory approvals and shareholder consent for merger, targeting June 1, 2026 closing.

Chinese eVTOL startup Autoflight's freight-focused strategy and successful testing of a cargo aircraft could outpace U.S. competitors Joby Aviation and Archer Aviation in the emerging urban air mobility market.

Nvidia partners with Oklo and Los Alamos Lab to develop AI-powered nuclear research and data centers, tapping into a $10 trillion energy opportunity.

Novo Nordisk reports positive phase 3a trial results for oral semaglutide in children with type 2 diabetes, planning 2026 regulatory filings for potential first pediatric GLP-1 approval.